Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Desager

Showing results (31-40 of 106) with videos related to

Pageof 11
Sort By:
Journal of Clinical Pharmacology|October 1, 1980
Uricosuric effect of fenofibrate in healthy volunteersJ P Desager, R Hulhoven, C Harvengt
Artery|January 1, 1980
Hypolipidemic and hypouricemic action of fenofibrate in various types of hyperlipoproteinemiasC Harvengt, F Heller, J P Desager
Clinical Pharmacology and Therapeutics|September 5, 1998
Inhibition of chlorzoxazone metabolism, a clinical probe for CYP2E1, by a single ingestion of watercressI Leclercq, J P Desager, Y Horsmans
Acta Cardiologica. Supplementum|January 1, 1981
Plasma lipid concentrations and lecithin: cholesterol acyltransferase activity in normolipidemic subjects given fenofibrate and colestipolF Heller, J P Desager, C Harvengt
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 30, 1993
Effects of gemfibrozil on the activities of plasma lipolytic enzymes in normolipidemic subjectsY Horsmans, J P Desager, C Harvengt
Life Sciences|January 1, 1993
Scoparone O-demethylase assay is not useful to differentiate the effects of model inducers of cytochrome P-450 in rabbit and guinea pig liverY Horsmans, J P Desager, C Harvengt
Pharmacology & Toxicology|October 1, 1992
Absence of CYP3A genetic polymorphism assessed by urinary excretion of 6 beta-hydroxycortisol in 102 healthy subjects on rifampicinY Horsmans, J P Desager, C Harvengt
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1991
Is there a link between debrisoquine oxidation phenotype and lung cancer susceptibility?Y Horsmans, J P Desager, C Harvengt
Research Communications in Chemical Pathology and Pharmacology|August 1, 1989
Hypotriglyceridemic action of omega-3 fatty acids in healthy subjects does not occur by enhanced lipoprotein lipase and hepatic lipase activitiesJ P Desager, J Dricot, C Harvengt
Pharmacology & Toxicology|February 1, 1996
Relationship between mephenytoin, phenytoin and tolbutamide hydroxylations in healthy African subjectsY Horsmans, J M Kanyinda, J P Desager
Pageof 11

Showing results (31-40 of 106) with videos related to

Sort By:
Pageof 11
Journal of Clinical Pharmacology|October 1, 1980
Uricosuric effect of fenofibrate in healthy volunteersJ P Desager, R Hulhoven, C Harvengt
Artery|January 1, 1980
Hypolipidemic and hypouricemic action of fenofibrate in various types of hyperlipoproteinemiasC Harvengt, F Heller, J P Desager
Clinical Pharmacology and Therapeutics|September 5, 1998
Inhibition of chlorzoxazone metabolism, a clinical probe for CYP2E1, by a single ingestion of watercressI Leclercq, J P Desager, Y Horsmans
Acta Cardiologica. Supplementum|January 1, 1981
Plasma lipid concentrations and lecithin: cholesterol acyltransferase activity in normolipidemic subjects given fenofibrate and colestipolF Heller, J P Desager, C Harvengt
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 30, 1993
Effects of gemfibrozil on the activities of plasma lipolytic enzymes in normolipidemic subjectsY Horsmans, J P Desager, C Harvengt
Life Sciences|January 1, 1993
Scoparone O-demethylase assay is not useful to differentiate the effects of model inducers of cytochrome P-450 in rabbit and guinea pig liverY Horsmans, J P Desager, C Harvengt
Pharmacology & Toxicology|October 1, 1992
Absence of CYP3A genetic polymorphism assessed by urinary excretion of 6 beta-hydroxycortisol in 102 healthy subjects on rifampicinY Horsmans, J P Desager, C Harvengt
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1991
Is there a link between debrisoquine oxidation phenotype and lung cancer susceptibility?Y Horsmans, J P Desager, C Harvengt
Research Communications in Chemical Pathology and Pharmacology|August 1, 1989
Hypotriglyceridemic action of omega-3 fatty acids in healthy subjects does not occur by enhanced lipoprotein lipase and hepatic lipase activitiesJ P Desager, J Dricot, C Harvengt
Pharmacology & Toxicology|February 1, 1996
Relationship between mephenytoin, phenytoin and tolbutamide hydroxylations in healthy African subjectsY Horsmans, J M Kanyinda, J P Desager
Pageof 11